Abstract
Autism spectrum disorder (ASD) is a developmental disability that can cause significant social, communication and behavioral challenges. Many challenges remain for ASD diagnosis and treatments. Current diagnostic criteria are based on behavioral symptoms alone. Wait times for appointments at diagnostic centers range from 9 to 13 months, and a single diagnostic appointment can last several hours. There is an urgent need to identify ASD associated biomarkers and features to help automate diagnostics and develop predictive ASD models. The present study adopts a novel evolutionary algorithm, the conjunctive clause evolutionary algorithm (CCEA), to select features most significant for distinguishing individuals with and without ASD using a unique dataset having a small number of samples with a very large number of feature measurements. The dataset comprises both behavioral and neuroimaging measurements from a total of 21 children from 7 to 14 years old. Potential biomarker candidates including volume, area, cortical thickness and mean curvature in specific regions in the cingulate cortex, frontal cortex and temporal-parietal junction areas were identified. Behavioral features associated with theory of mind were selected. Study findings demonstrate how machine learning tools can advance ASD research in the genre of big data to benefit this special population in the future.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This project was supported by a private donor committed to advancing research in autism spectrum disorder, as well as pilot MRI scan research funding from the MRI research unit at the University of Vermont.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The research is approved by the IRB office at the University of Vermont, protocol number is 19-0005.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data in this manuscript was collected by the research team under Dr. Patricia Prelock, access can be granted upon request.
